Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DaJiMed is a medical technology company based in Shanghai, China, that specializes in the research, development, and manufacturing of interventional medical devices. The company primarily focuses on cardiovascular and peripheral vascular interventions, offering a product portfolio that includes PTCA balloon dilatation catheters, high-pressure balloon catheters, and various interventional guidewires. DaJiMed aims to provide high-quality, innovative solutions for minimally invasive surgeries to improve patient outcomes in vascular health. Their manufacturing facilities adhere to international quality standards, such as ISO 13485, supporting both domestic and global market expansion. The company's R&D efforts are directed toward enhancing the performance and safety of vascular access and dilation tools through advanced materials and precision engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DaJiMed.